IL-9 neutralizing antibody plays a therapeutic role in mice with allergic rhinitis, possibly through the TSLP-OX40/OX40L signal pathway and JAK1/2-STAT5 signal. The gene discussed is TNFSF4; the disease is allergic rhinitis.